Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's ...

The FDA bestows a Fast Track designation to Johnson & Johnson's nipocalimab for treating moderate-to-severe Sjogren's disease ...

*Pooled data analysis from 22 studies. † Lupus in minorities: nature versus nurture [Unpublished Observ., May 2008]. Lupus occurs only in young women Lupus may occur at any age and in both ...

Experts And Viewpoints, June 13, 2000 Ask the Experts - Is There a Risk of Thrombosis in a Patient With SLE... I have a 10-year-old female patient who has systemic lupus erythematosus (SLE ...

Leerink Partners 2025 Global Healthcare Conference Call March 12, 2025 11:20 AM ETCompany ParticipantsRoland Chen ...

which was in testing for various indications including SLE, but now only has Sjogren's syndrome listed in Novartis' latest pipeline update.

To date, findings show that the expression of IL-27 is abnormal in different inflammatory autoimmune diseases (including systemic lupus erythematosus, rheumatoid arthritis, Sjogren syndrome, Behcet’s ...

Among prevalent IIM cases, 14% had a diagnosis of other autoimmune conditions including rheumatoid arthritis (9%), systemic lupus erythematosus (3%), systemic sclerosis (4%), or Sjogren’s disease (2%) ...

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that causes widespread inflammation. It can affect the skin, joints, blood vessels, and multiple organ systems. The exact cause ...

Genome-wide association studies and fine mapping of candidate regions have rapidly advanced our understanding of the genetic basis of systemic lupus erythematosus (SLE). More than 20 robust ...